Intellectual Property India Publishes Patent Application for Systemic Isoxazoline Parasiticides For Vector-Borne And Viral Disease Treatment Or Prophylaxis

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202618083099 A) filed by Tarsus Pharmaceuticals, Inc. on July 06, 2026, for Systemic Isoxazoline Parasiticides For Vector-Borne And Viral Disease Treatment Or Prophylaxis.

Inventors include Azamian, Bobak, Robert; Ackermann, Douglas, Michael; Stivers, Christopher; and Hickok, Shawn, D..

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: ABSTRACT SYSTEMIC ISOXAZOLINE PARASITICIDES FOR VECTOR-BORNE AND VIRAL DISEASE TREATMENT OR PROPHYLAXIS Disclosed herein are methods of treating or preventing infections associated with organisms, or preventing vector-borne diseases including Plasmodium infestation and/5 or malaria via delivery of one, two, or more systemic doses of an isoxazoline anti-parasitic therapeutic agent to an individual with confirmed or suspected infestation of Plasmodium and/or malaria.

Disclaimer: Curated by HT Syndication.